A pioneering clinical trial will investigate the use of cannabidiol (CBD) - a compound found in the cannabis plant - in people with...

“This is an exciting new approach that could rescue defective mitochondria inside neurons to prevent dysfunction and degeneration of dopamin

Parkinson’s UK have partnered with NRG Therapeutics to find a drug that could protect dopamine cells damaged by the condition Charity...

The US Food and Drug Administration (FDA) gave a positive response to Neurolixis’ Investigational New Drug (IND) application for NLX-112....

Results from a pioneering clinical trials programme that delivered an experimental treatment directly to the brain offer hope that it may...

Parkinson’s UK has today announced that it is investing a further £1.5million to advance its exciting drug discovery programme to develop...